000627.SZ
Price:
$2.6
Market Cap:
$12.85B
Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. The company also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, it is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. The company exports its products to the United States, the European Union, and internationally. Hubei Biocause Pharmaceutical Co., Ltd. is based in Jingmen, China.
Industry
Insurance - Life
IPO Date
1996-11-12
Stock Exchange
SHZ
Ticker
000627.SZ
According to Hubei Biocause Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -17.33. This represents a change of -181.25% compared to the average of 21.33 of the last 4 quarters.
The mean historical PE Ratio of Hubei Biocause Pharmaceutical Co., Ltd. over the last ten years is 26.11. The current -17.33 PE Ratio has changed -6737.21% with respect to the historical average. Over the past ten years (40 quarters), 000627.SZ's PE Ratio was at its highest in in the December 2020 quarter at 1.44K. The PE Ratio was at its lowest in in the June 2015 quarter at -214.78.
Average
26.11
Median
21.15
Minimum
-21.62
Maximum
75.17
Discovering the peaks and valleys of Hubei Biocause Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 80.87%
Maximum Annual PE Ratio = 75.17
Minimum Annual Increase = -315.17%
Minimum Annual PE Ratio = -21.62
Year | PE Ratio | Change |
---|---|---|
2023 | -21.62 | -170.70% |
2022 | 30.58 | 64.57% |
2021 | 18.58 | -13.68% |
2020 | 21.52 | 80.87% |
2019 | 11.90 | -42.73% |
2018 | 20.78 | -23.14% |
2017 | 27.03 | 55.49% |
2016 | 17.39 | -70.92% |
2015 | 59.78 | -20.47% |
2014 | 75.17 | -315.17% |
The current PE Ratio of Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.18
5-year avg
12.19
10-year avg
26.11
Hubei Biocause Pharmaceutical Co., Ltd.’s PE Ratio is less than Changjiang Securities Company Limited (16.77), less than Jilin Aodong Pharmaceutical Group Co., Ltd. (10.07), less than Guoyuan Securities Company Limited (14.07), less than Tongling Nonferrous Metals Group Co.,Ltd. (15.06), less than Hbis Company Limited (34.96),
Company | PE Ratio | Market cap |
---|---|---|
16.77 | $38.82B | |
10.07 | $20.33B | |
14.07 | $34.82B | |
15.06 | $43.22B | |
34.96 | $24.29B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hubei Biocause Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hubei Biocause Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Hubei Biocause Pharmaceutical Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ)?
What is the highest PE Ratio for Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ)?
What is the 3-year average PE Ratio for Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ)?
What is the 5-year average PE Ratio for Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ)?
How does the current PE Ratio for Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) compare to its historical average?